This year’s meeting of the American Society of Clinical Oncology is abuzz with talk of RAS inhibitors, largely driven by Revolution Medicines’ barnburner pancreatic cancer data drop earlier this year.
In one of the most far-reaching changes to Pakistan's higher education admission system in recent years, Higher Education Commission Pakistan has centralised the MPhil and PhD admission process by ...
The Higher Education Commission of Pakistan (HEC) on Monday announced the launch of a “fully online and paperless” degree attestation system to facilitate students. In December last year, the HEC said ...
AACR was full of biotechs showcasing their preclinical Ras candidates, including Clasp Therapeutics, Verastem Oncology and BlossomHill Therapeutics. (Darren Incorvaia) After dropping headline-grabbing ...
PARIS — RAS Luxury Skincare, the Indian farm-to-face brand, closed a 65 Crores, or $7.5 million, Series B funding round led by Dabur Ventures. Dabur Ventures is the venture arm of the largest ...
Fintech company Block said Thursday that it’s cutting more than 4,000 workers or nearly half of its workforce as artificial intelligence disrupts the way people work. The Oakland parent company of ...
Block to cut over 4,000 jobs CEO says AI has changed how a company is run Stock surges 25% after market Analysts call cuts a "seminal moment" in AI era Feb 26 (Reuters) - Block (XYZ.N), opens new tab ...
Block, the company behind Square, Cash App and Afterpay, is cutting its staff by 40%. The reason: “intelligence tools,” according to a letter to shareholders by co-founder Jack Dorsey. Dorsey thinks ...
About 4,000 workers will lose their jobs as the payments company does more work with new artificial intelligence tools, its top executive said. By Natallie Rocha Reporting from San Francisco Block, ...
The MarketWatch News Department was not involved in the creation of this content. -- Chemoproteomics screening platform identified novel covalent inhibitors that specifically disrupt RAS-mediated ...
Vividion Therapeutics, Inc. (Vividion), a clinical-stage biopharmaceutical company, and a wholly owned and independently operated subsidiary of Bayer AG, today announced the publication of a ...
Bain Capital agreed to sell its data centers in China to Shenzhen Dongyangguang Industry Co. in a transaction valued at about $4 billion. Shenzhen Dongyangguang, the parent of Shanghai-listed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results